Dry Omega uses a blend of natural marine and plant oils for stability and freshness
Supplements
When managing dry eye symptoms it is important to address all aspects of this multifactorial disease including ocular surface inflammation and resulting damage.1
The role of dietary modifications has been well documented in dry eye management including the role of essential fatty acids (EFAs) as an anti-inflammatory agent.2
If, like many dry eye specialists, you take this more holistic approach to alleviating symptoms then you need to know that with Dry Omega from Eye Nutrients, you are recommending a best-in-class supplement to your patient.
Dry Omega
Dry Omega’s unique, balanced, sustainable and non esterified oil is produced from small fish and is free-from additives or concentrates.
The DHA omega fatty acids are mixed with natural marine and plant oils, making them more stable and effective for longer, with no fishy after-taste or side effects.
Contains three Omega-3 essential fatty acids
- EPA – helps reduce inflammation in dry eyes.
- DHA – helps rebuild damaged cells on the surface of the eye.
- DPA – a very strong anti-inflammatory to help soothe dry eyes.
Benefits of Dry Omega
A unique blend
A blend of natural marine and plant oils for stability and freshness.
Great taste
A highly palatable taste for greater patient compliance
Omega-7 essential fatty acid
Helps retain moisture in the membranes of the eye.
Vitamin D3
Helps reduce ocular inflammation and increase tear film.
No fishy smell or taste
Omega-3 can become oxidised and smell, Eye Nutrients Dry Omega is fresher and more stable than other Omega-3 products.
Beef free
Capsules made from fish gelatin, not beef.
Formulated by experts
Eye Nutrients was developed by consultant ophthalmologists specifically for eye health.
Two formats
Available in 1500mg capsules (take 2 per day)
Our Downloads
Dry Omega Brochure
PDF, 624KB
Circle of Care - Supplements
PDF, 359KB
Interested in using Dry Omega in your practice?
Contact us to find out more about Dry Omega and to order.
References
1. J Craig et al. TFOS DEWS II Definition and Classification Report. The Ocular Surface Volume 15, Issue 3, July 2017, 276-283
2. L. Jones et al. TFOS DEWS II Management and Therapy Report. The Ocular Surface. Volume 15, Issue 3, July 2017, 607-611
Read the news on
Positive Impact
Positive Impact (PI) confirms that its exclusive partnership with CSI Innovations (CSI) formerly known as CSI Dry Eye Software, has ended under a revised UK distribution structure for the Canadian software brand.
The opticians’ favourite lens cleaning system is now more accessible than ever. We’ve removed the barrier of initial capital investment so you can focus on patient loyalty and practice growth.
Positive Impact (PI) will be showing its independent-only portfolio and launching two new diagnostic instruments.
This will be the debut for the return of the Keratron topographer range to the UK.